Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Eisai Co. Ltd.

ESAIY
Current price
9.28 USD -0.09 USD (-0.96%)
Last closed 5 546 JPY
ISIN JP3160400002
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange TSE
Capitalization 1 569 294 167 815 JPY
Yield for 12 month -32.63 %
1Y
3Y
5Y
10Y
15Y
ESAIY
21.11.2021 - 28.11.2021

Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan. It offers Dayvigo, for the treatment of insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; Methycobal for the treatment of peripheral neuropathy; and Halaven, an anticancer agent for the treatment of breast cancer. The company also provides Jyseleca, a janus kinase inhibitor; Elental, a branched-chain amino acid preparation; Goofice and Movicol for chronic constipation; Fycompa, an antiepileptic agent; Pariet, a proton-pump inhibitor; Aricept, for Alzheimer's disease/Dementia with Lewy bodies; and Chocola BB plus for the preparation vitamin B2. It has strategic collaboration with Bristol Myers Squibb for the co-development and co-commercialization of farletuzumab ecteribulin antibody drug conjugate. Eisai Co., Ltd. was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan. Address: 4-6-10, Koishikawa, Tokyo, Japan, 112-8088

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

1 164 130.07 JPY

P/E ratio

48.7798

Dividend Yield

2.88 %

Current Year

+742 000 404 693 JPY

Last Year

+744 652 296 075 JPY

Current Quarter

+189 092 558 642 JPY

Last Quarter

+190 560 052 013 JPY

Current Year

+563 963 562 092 JPY

Last Year

+566 755 500 518 JPY

Current Quarter

+149 322 190 811 JPY

Last Quarter

+154 441 911 812 JPY

Key Figures ESAIY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 71 457 021 488 JPY
Operating Margin TTM 7.09 %
PE Ratio 48.7798
Return On Assets TTM 1.46 %
PEG Ratio
Return On Equity TTM 3.85 %
Wall Street Target Price 1 164 130.07 JPY
Revenue TTM 734 091 742 482 JPY
Book Value 3 138.34 JPY
Revenue Per Share TTM
Dividend Share 160.05 JPY
Quarterly Revenue Growth YOY -4 %
Dividend Yield 2.88 %
Gross Profit TTM 566 755 500 538 JPY
Earnings per share 112.73 JPY
Diluted Eps TTM 112.73 JPY
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -47.9 %
Profit Margin 4.45 %

Dividend Analytics ESAIY

Dividend growth over 5 years

7 %

Continuous growth

1 year

Payout Ratio 5 years average

42 %

Dividend History ESAIY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 160
Ex Dividend Date 28.03.2025
Forward Annual Dividend Yield 2.88 %
Last Split Factor
Payout Ratio 2.08 %
Last Split Date
Dividend Date

Stock Valuation ESAIY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 48.7798
Forward PE 32.6797
Enterprise Value Revenue 1.9203
Price Sales TTM 2.1377
Enterprise Value EBITDA 15.3533
Price Book MRQ 1.7758

Financials ESAIY

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ESAIY

For 52 weeks

4 915.86 JPY 8 237.7 JPY
50 Day MA 5 802.33 JPY
Shares Short Prior Month
200 Day MA 6 398.3 JPY
Short Ratio
Shares Short
Short Percent